LI-RADS v2018 category and imaging features: inter-modality agreement between contrast-enhanced CT, gadoxetate disodium-enhanced MRI, and extracellular contrast-enhanced MRI

被引:0
作者
Agnello, Francesco [1 ]
Cannella, Roberto [1 ]
Brancatelli, Giuseppe [1 ]
Galia, Massimo [1 ]
机构
[1] Univ Palermo, Dept Radiol, Policlin Paolo Giaccone, Via Vespro 127, I-90127 Palermo, Italy
来源
RADIOLOGIA MEDICA | 2024年 / 129卷 / 11期
关键词
LI-RADS; CT; MRI; Liver; Contrast media; GD-EOB-DTPA; FOCAL LIVER-LESIONS; SMALL HEPATOCELLULAR-CARCINOMA; COMPUTED-TOMOGRAPHY; DELAYED PHASE; DIAGNOSTIC PERFORMANCE; SIGNAL-INTENSITY; HEPATIC NODULES; CIRRHOTIC LIVER; ACID;
D O I
10.1007/s11547-024-01879-8
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PurposeTo perform an intra-individual comparison of LI-RADS category and imaging features in patients at high risk of hepatocellular carcinoma (HCC) on contrast-enhanced CT, gadoxetate disodium-enhanced MRI (EOB-MRI), and extracellular agent-enhanced MRI (ECA-MRI) and to analyze the diagnostic performance of each imaging modality.MethodThis retrospective study included cirrhotic patients with at least one LR-3, LR-4, LR-5, LR-M or LR-TIV observation imaged with at least two imaging modalities among CT, EOB-MRI, or ECA-MRI. Two radiologists evaluated the observations using the LI-RADS v2018 diagnostic algorithm. Reference standard included pathologic confirmation and imaging criteria according to LI-RADS v2018. Imaging features were compared between different exams using the McNemar test. Inter-modality agreement was calculated by using the weighted Cohen's kappa (k) test.ResultsA total of 144 observations (mean size 34.0 +/- 32.4 mm) in 96 patients were included. There were no significant differences in the detection of major and ancillary imaging features between the three imaging modalities. When considering all the observations, inter-modality agreement for category assignment was substantial between CT and EOB-MRI (k 0.60; 95%CI 0.44, 0.75), moderate between CT and ECA-MRI (k 0.46; 95%CI 0.22, 0.69) and substantial between EOB-MRI and ECA-MRI (k 0.72; 95%CI 0.59, 0.85). In observations smaller than 20 mm, inter-modality agreement was fair between CT and EOB-MRI (k 0.26; 95%CI 0.05, 0.47), moderate between CT and ECA-MRI (k 0.42; 95%CI -0.02, 0.88), and substantial between EOB-MRI and ECA-MRI (k 0.65; 95%CI 0.47, 0.82). ECA-MRI demonstrated the highest sensitivity (70%) and specificity (100%) when considering LR-5 as predictor of HCC.ConclusionsInter-modality agreement between CT, ECA-MRI, and EOB-MRI decreases in observations smaller than 20 mm. ECA-MRI has the provided higher sensitivity for the diagnosis of HCC.
引用
收藏
页码:1575 / 1586
页数:12
相关论文
共 50 条
  • [31] Data-Driven Modification of the LI-RADS Major Feature System on Gadoxetate Disodium-Enhanced MRI: Toward Better Sensitivity and Simplicity
    Jiang, Hanyu
    Song, Bin
    Qin, Yun
    Wei, Yi
    Konanur, Meghana
    Wu, Yuanan
    Zaki, Islam H.
    McInnes, Matthew D. F.
    Lafata, Kyle J.
    Bashir, Mustafa R.
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2022, 55 (02) : 493 - 506
  • [32] Effect of combining serum alpha-fetoprotein with LI-RADS v2018 on gadoxetate-enhanced MRI in the diagnosis and prognostication of hepatocellular carcinoma
    Kim, Dong Hwan
    Choi, Sang Hyun
    Koo, Boyeon
    Choi, Se Jin
    Jang, Hyeon Ji
    Heo, Subin
    Byun, Jae Ho
    Won, Hyung Jin
    Shin, Yong Moon
    EUROPEAN RADIOLOGY, 2025,
  • [33] Extended application of subtraction arterial phase imaging in LI-RADS version 2018: a strategy to improve the diagnostic performance for hepatocellular carcinoma on gadoxetate disodium-enhanced MRI
    Kim, Seung-seob
    Lee, Sunyoung
    Bae, Heejin
    Chung, Yong Eun
    Choi, Jin-Young
    Park, Mi-Suk
    Kim, Myeong-Jin
    EUROPEAN RADIOLOGY, 2021, 31 (03) : 1620 - 1629
  • [34] Fusion Imaging of Contrast-enhanced Ultrasound With CT or MRI for Kidney Lesions
    Auer, Thomas
    Heidegger, Isabel
    De Zordo, Tobias
    Junker, Daniel
    Jaschke, Werner
    Steinkohl, Fabian
    Aigner, Friedrich
    IN VIVO, 2019, 33 (01): : 203 - 208
  • [35] Profiling hepatocellular carcinoma aggressiveness with contrast-enhanced ultrasound and gadoxetate disodium-enhanced MRI: An intra-individual comparative study based on the Liver Imaging Reporting and Data System
    Yang, Jie
    Jiang, Hanyu
    Xie, Kunlin
    Bashir, Mustafa R.
    Wan, Haifeng
    Huang, Jiayan
    Qin, Yun
    Chen, Jie
    Lu, Qiang
    Song, Bin
    EUROPEAN JOURNAL OF RADIOLOGY, 2022, 154
  • [36] Unraveling distinctions between contrast-enhanced ultrasound and CT/MRI for liver mass diagnosis
    Murad, Vanessa
    Jang, Hyun-Jung
    Kim, Tae Kyoung
    ULTRASONOGRAPHY, 2025, 44 (01) : 19 - 30
  • [37] The role of enhancing capsule and modified capsule appearances in LI-RADS for diagnosing HCC ≤ 3.0 cm on gadoxetate disodium-enhanced MRI
    Pan, Junhan
    Song, Mengchen
    Yang, Lili
    Zhao, Yanci
    Zhu, Yanyan
    Wang, Meng
    Chen, Feng
    EUROPEAN RADIOLOGY, 2023, 33 (08) : 5801 - 5811
  • [38] Inter-rater agreement in the characterization of cystic renal lesions on contrast-enhanced MRI
    Nicholas Seppala
    Ania Kielar
    Dominique Dabreo
    Shauna Duigenan
    Abdominal Imaging, 2014, 39 : 1267 - 1273
  • [39] Leiomyosarcomas of the inferior vena cava: diagnostic features on contrast-enhanced CT, ultrasonography and MRI
    Xu, Xiaolin
    Zhao, Shilei
    Xue, Lifang
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [40] A nomogram based on LI-RADS features, clinical indicators and quantitative contrast-enhanced MRI parameters for predicting glypican-3 expression in hepatocellular carcinoma
    Song, Yan
    Zhang, Yue-yue
    Yu, Qin
    Chen, Tong
    Wei, Chao-gang
    Zhang, Rui
    Hu, Wei
    Qian, Xu-jun
    Zhu, Zhi
    Zhang, Xue-wu
    Shen, Jun-kang
    FRONTIERS IN ONCOLOGY, 2023, 13